je.st
news
Galena Biopharma Raised to "Outperform" at Oppenheimer
2015-11-15 17:14:57| Biotech - Topix.net
The brokerage currently has a $4.00 price target on the biotechnology company's stock. Oppenheimer's target price suggests a potential upside of 166.67% from the company's previous close.
Tags: raised
outperform
oppenheimer
biopharma
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||